Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Plant Physiol ; 224-225: 163-172, 2018.
Article in English | MEDLINE | ID: mdl-29656008

ABSTRACT

Tef [Eragrostis tef (Zucc.) Trotter], a staple food crop in the Horn of Africa and particularly in Ethiopia, has several beneficial agronomical and nutritional properties, including waterlogging and drought tolerance. In this study, we performed microRNA profiling of tef using the Illumina HiSeq 2500 platform, analyzing both shoots and roots of two tef genotypes, one drought-tolerant (Tsedey) and one drought-susceptible (Alba). We obtained more than 10 million filtered reads for each of the 24 sequenced small cDNA libraries. Reads mapping to known miRNAs were more abundant in the root than shoot tissues. Thirteen and 35 miRNAs were significantly modulated in response to drought, in Alba and Tsedey roots, respectively. One miRNA was upregulated under drought conditions in both genotypes. In shoots, nine miRNAs were modulated in common between the two genotypes and all showed similar trends of expression. One-hundred and forty-seven new miRNA mature sequences were identified in silico, 22 of these were detected in all relevant samples and seven were differentially regulated when comparing drought with normal watering. Putative targets of the miRNA regulated under drought in root and shoot tissues were predicted. Among the targets were transcription factors such as CCAAT-HAP2, MADS and NAC. Verification with qRT-PCR revealed that five of six potential targets showed a pattern of expression that was consistent with the correspondent miRNA amount measured by RNA-Seq. In general, candidate miRNAs involved in the post-transcriptional regulation of the tef response to drought could be included in next-generation breeding programs.


Subject(s)
Droughts , Eragrostis/physiology , MicroRNAs/genetics , RNA, Plant/genetics , Eragrostis/genetics , Genotype , MicroRNAs/metabolism , Plant Roots/genetics , Plant Roots/physiology , Plant Shoots/genetics , Plant Shoots/physiology , RNA, Plant/metabolism
2.
Infect Genet Evol ; 14: 282-93, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23201849

ABSTRACT

Members of the Picornaviridae family are non-enveloped, positive-stranded RNA viruses with a 30nm icosahedral capsid. This virus family exhibits a considerable amount of genetic variability driven both by mutation and recombination. Recently, three previously unknown human picornaviruses, namely the human Saffold cardiovirus, cosavirus and salivirus, have been identified in stools or respiratory samples from subjects presenting symptoms ranging from gastroenteritis to acute flaccid paralysis. However, these viruses were also frequently detected in asymptomatic subjects and their clinical relevance remains to be elucidated. The Enterovirus genus is a prototype example of the Picornaviridae heterogeneity at both genetic and phenotypic levels. This genus is divided into 10 species, seven of which contain human viruses, including three Rhinovirus species. Both human rhino- and enteroviruses are also characterized by high levels of genetic variability, as exemplified by the existence of over 250 different serotypes and the recent discovery of new enterovirus genotypes and the Rhinovirus C species. Despite their common genomic features, rhinoviruses are restricted to the respiratory tract, whereas the vast majority of enteroviruses infect the gastrointestinal tract and can spread to other organs, such as the heart or the central nervous system. Understanding the genetic determinants of such phenotypic diversity is an important challenge and a field for future investigation. Better characterization of these ubiquitous human pathogens may help to develop vaccines or antiviral treatments and to monitor the emergence of new strains.


Subject(s)
Enterovirus Infections/epidemiology , Enterovirus/genetics , Genetic Variation , Picornaviridae Infections/epidemiology , Picornaviridae/genetics , Enterovirus/classification , Enterovirus Infections/virology , Humans , Phenotype , Picornaviridae/classification , Picornaviridae Infections/virology
3.
J Interferon Cytokine Res ; 31(8): 601-8, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21413873

ABSTRACT

The interferon (IFN)-α response gene interferon-induced transmembrane protein 3 (IFITM3) has antiproliferative properties in a number of biological systems. In the human melanoma cell line D10, IFITM3 is constitutively expressed and we show that the core promoter is significantly hypomethylated compared to ME15 cells, where IFITM3 is tightly controlled. We demonstrate that treatment of ME15 cells with the demethylating agent 5'-aza-2'-deoxycytidine enhances IFITM3 expression after IFN-α treatment. In a time-course experiment, we show that IFN-α induces demethylation of specific CpG sites of the IFITM3 core promoter 6 h after stimulation and that promoter methylation is precisely re-set to the naïve state 24 h after stimulation. This cyclable modification of methylation requires costimulation with tumor growth factor-beta or expression of the calcium binding protein S100A2, which are known cofactors for enhancement of antiproliferative activity in ME15 cells. Thus, the transcriptional response to IFN-α can be enhanced by promoter demethylation of a subset of inducible genes such as IFITM3. This epigenetic modulation might be crucial to augment the immune response under critical conditions in vivo.


Subject(s)
Biomarkers, Pharmacological/metabolism , Interferon-alpha/pharmacology , Melanoma/drug therapy , Melanoma/metabolism , Membrane Proteins/metabolism , RNA-Binding Proteins/metabolism , Azacitidine/analogs & derivatives , Azacitidine/pharmacology , Cell Growth Processes/drug effects , Cell Line, Tumor , Chemotactic Factors/genetics , Chemotactic Factors/metabolism , DNA Methylation/drug effects , DNA Modification Methylases/antagonists & inhibitors , Decitabine , Gene Expression Regulation, Neoplastic/drug effects , Humans , Melanoma/genetics , Melanoma/pathology , Membrane Proteins/genetics , Promoter Regions, Genetic/genetics , RNA-Binding Proteins/genetics , S100 Proteins/genetics , S100 Proteins/metabolism , Transforming Growth Factor beta/metabolism , Transgenes/genetics
4.
Nature ; 470(7334): 419-23, 2011 Feb 17.
Article in English | MEDLINE | ID: mdl-21278727

ABSTRACT

Thymine DNA glycosylase (TDG) is a member of the uracil DNA glycosylase (UDG) superfamily of DNA repair enzymes. Owing to its ability to excise thymine when mispaired with guanine, it was proposed to act against the mutability of 5-methylcytosine (5-mC) deamination in mammalian DNA. However, TDG was also found to interact with transcription factors, histone acetyltransferases and de novo DNA methyltransferases, and it has been associated with DNA demethylation in gene promoters following activation of transcription, altogether implicating an engagement in gene regulation rather than DNA repair. Here we use a mouse genetic approach to determine the biological function of this multifaceted DNA repair enzyme. We find that, unlike other DNA glycosylases, TDG is essential for embryonic development, and that this phenotype is associated with epigenetic aberrations affecting the expression of developmental genes. Fibroblasts derived from Tdg null embryos (mouse embryonic fibroblasts, MEFs) show impaired gene regulation, coincident with imbalanced histone modification and CpG methylation at promoters of affected genes. TDG associates with the promoters of such genes both in fibroblasts and in embryonic stem cells (ESCs), but epigenetic aberrations only appear upon cell lineage commitment. We show that TDG contributes to the maintenance of active and bivalent chromatin throughout cell differentiation, facilitating a proper assembly of chromatin-modifying complexes and initiating base excision repair to counter aberrant de novo methylation. We thus conclude that TDG-dependent DNA repair has evolved to provide epigenetic stability in lineage committed cells.


Subject(s)
Embryo, Mammalian/embryology , Embryo, Mammalian/metabolism , Embryonic Development/genetics , Epigenesis, Genetic/genetics , Genes, Lethal/genetics , Phenotype , Thymine DNA Glycosylase/metabolism , Animals , Cell Differentiation/genetics , Cell Lineage/genetics , Chromatin/genetics , Chromatin/metabolism , CpG Islands/genetics , DNA Methylation , DNA Repair , Embryo, Mammalian/enzymology , Fibroblasts/metabolism , Gene Deletion , Gene Expression Regulation, Developmental , Genes, Essential/genetics , Histones/metabolism , Mice , Mice, Knockout , Promoter Regions, Genetic/genetics , Thymine DNA Glycosylase/deficiency , Thymine DNA Glycosylase/genetics
5.
J Interferon Cytokine Res ; 31(1): 183-97, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21166591

ABSTRACT

Interferon-induced transmembrane (IFITM) genes are transcribed in most tissues and are with the exception of IFITM5 interferon inducible. They are involved in early development, cell adhesion, and control of cell growth. Most IFITM genes are activated in response to bacterial and viral infections, and the exact host immune defense mechanisms are still unknown. Elevated gene expression triggered by past or chronic inflammation could prevent spreading of pathogens by limiting host cell proliferation. Accordingly, induction in cells with low basal protein levels is sufficient to drive growth arrest and a senescence-like morphology. On the other hand, loss of IFITM levels in cancer is correlated with pronounced malignancy; thus, these genes are considered as tumor suppressors. However, several cancer cells have deregulated high levels of IFITM transcripts, indicating a tumor progression stage where at least one of the interferon-controlled antiproliferative pathways has been silenced. Phylogenetic analyses of the protein coding genomic sequences suggest a single interferon-inducible gene in the common ancestor of rodents and primates. Biological functions studied so far may have evolved in parallel, and functional characterization of IFITM proteins will provide insight into innate immune defense, cancer development, and other pathways.


Subject(s)
Antigens, Differentiation/metabolism , Gene Expression Regulation , Interferons/metabolism , Membrane Proteins/metabolism , Multigene Family , RNA-Binding Proteins/metabolism , Animals , Antigens, Differentiation/chemistry , Antigens, Differentiation/genetics , Embryonic Development , Gene Expression Regulation/drug effects , Humans , Immunity, Innate/drug effects , Interferons/pharmacology , Membrane Proteins/chemistry , Membrane Proteins/genetics , Neoplasms/immunology , Neoplasms/metabolism , Phylogeny , Promoter Regions, Genetic/drug effects , Protein Interaction Domains and Motifs , Protein Transport , RNA-Binding Proteins/chemistry , RNA-Binding Proteins/genetics , Sequence Homology, Amino Acid , Virus Diseases/immunology , Virus Diseases/metabolism
6.
Biol Proced Online ; 11: 113-29, 2009 Jul 23.
Article in English | MEDLINE | ID: mdl-19629613

ABSTRACT

MicroRNAs are positive and negative regulators of eukaryotic gene expression that modulate transcript abundance by specific binding to sequence motifs located prevalently in the 3' untranslated regions of target messenger RNAs (mRNA). Interferon-alpha-2a (IFNα) induces a large set of protein coding genes mediating antiproliferative and antiviral responses. Here we use a global microarray-based microRNA detection platform to identify genes that are induced by IFNα in hepatoma- or melanoma-derived human tumor cell lines. Despite the enormous differences in expression levels between these models, we were able to identify microRNAs that are upregulated by IFNα in both lines suggesting the possibility that interferon-regulated microRNAs are involved in the transcriptional repression of mRNA relevant to cytokine responses.

SELECTION OF CITATIONS
SEARCH DETAIL
...